Andrew Reardon - 24 Mar 2023 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Signature
/s/ Andrew Reardon
Issuer symbol
LGND
Transactions as of
24 Mar 2023
Net transactions value
-$20,977
Form type
4
Filing time
28 Mar 2023, 17:00:13 UTC
Previous filing
27 Feb 2023
Next filing
14 Aug 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGND Common Stock Sale $20,977 -300 -1.8% $69.92 16,308 24 Mar 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Chief Legal Officer and Secretary